Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Bioadaptives (BDPT) FCF Margin (2019 - 2025)

Historic FCF Margin for Bioadaptives (BDPT) over the last 7 years, with Q3 2025 value amounting to 3266.6%.

  • Bioadaptives' FCF Margin changed N/A to 3266.6% in Q3 2025 from the same period last year, while for Sep 2025 it was 5868.49%, marking a year-over-year decrease of 46592500.0%. This contributed to the annual value of 1969.51% for FY2024, which is 11861300.0% down from last year.
  • According to the latest figures from Q3 2025, Bioadaptives' FCF Margin is 3266.6%.
  • Bioadaptives' 5-year FCF Margin high stood at 343.35% for Q1 2024, and its period low was 7623.11% during Q2 2024.
  • In the last 5 years, Bioadaptives' FCF Margin had a median value of 1186.57% in 2022 and averaged 1756.51%.
  • Per our database at Business Quant, Bioadaptives' FCF Margin tumbled by -51918600bps in 2024 and then soared by 41753900bps in 2025.
  • Bioadaptives' FCF Margin (Quarter) stood at 919.32% in 2021, then rose by 25bps to 690.36% in 2022, then plummeted by -84bps to 1267.82% in 2023, then tumbled by -501bps to 7623.11% in 2024, then soared by 57bps to 3266.6% in 2025.
  • Its FCF Margin stands at 3266.6% for Q3 2025, versus 3447.72% for Q2 2025 and 7623.11% for Q2 2024.